P/B/737. Dissertation. GlaxoSmithKline (GSK): current financial position and strategic options

The dissertation investigates the strategic and financial position of GlaxoSmithKline (GSK), a global pharmaceutical company, examining the options for their future development and advising which of the options is best. Literature is reviewed on the subjects of merger and acquisition, profitability studies, divestiture, etc. The global pharmaceutical industry is analysed using Porter’s 5 forces model. Financial reports of GSK are studied; the history of the company’s mergers and acquisitions is reviewed; the key issues currently affecting GSK are analysed using SWOT; strategic options for GSK further development are discussed offering recommendations about the company restructuring.